跳到正文
原文
Endpoints News 生物医药· Kyle LaHucik·· 2026-10-19AI 评分14

Veradermics 口服米诺地尔制剂 VDphL01 在晚期试验中再次展现生发效果

Veradermics' oral Rogaine wins again at growing hair in late-stage trial

AI 导读

Veradermics 报告其口服缓释型米诺地尔制剂 VDphL01 在晚期临床试验中再次取得积极结果,显示出促进毛发生长的作用。该药物为罗盖因(Rogaine)的口服缓释版本。

正文

Ve­r­a­der­mics is tak­ing an­oth­er vic­to­ry lap with its oral twist on mi­nox­i­dil, com­mon­ly known as Ro­gaine.

The Con­necti­cut biotech said VD­PHL01, its ex­tend­ed-re­lease ver­sion of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news